Jeremy B Sussman
Associate Professor of Internal Medicine
2800 Plymouth Road B16-300W
ANN ARBOR
MI, 48109
[email protected]

Available to mentor

Jeremy B Sussman
Associate Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • About

    Dr. Sussman is a Research Scientist in the Center for Clinical Management Research at the Veterans Affairs Ann Arbor Health System and an Assistant Professor in the Department of Internal Medicine at the University of Michigan Medical School. He attended medical school at the University of California, San Francisco, completed internal medicine residency at Yale-New Haven Hospital, and was a Robert Wood Johnson Foundation Clinical Scholar at the University of Michigan. His research is focused on developing and implementing strategies to make clinical decisions more personalized and effective. He has focused on how using a patient’s risk of cardiovascular disease to guide treatment decisions. This has involved research that could alter how we use blood pressure medications and aspirin, along with projects on how to predict patient’s risk of having heart attacks and strokes, and work on the science of changing clinical behavior. The next stage of this research will focus on developing implementation techniques that will make these ideas useful and practical for clinical use.

    Qualifications
    • Fellowship in Health and Healthcare Research, Veteran Affairs Scholar
      University of Michigan, Robert Wood Johnson Clinical Scholars Program, 2011
    • Residency
      Yale New Haven Hospital, Department of Internal Medicine, 2008
    • Internship
      Yale New Haven Hospital, Department of Internal Medicine, 2006
    • MSc in Health and Medical Sciences
      University of California San Francisco Medical Center, San Francisco, 2003
    Center Memberships
    • Center Member
      Caswell Diabetes Institute
    • Center Member
      Center for Bioethics and Social Sciences in Medicine
    • Center Member
      Institute for Healthcare Policy and Innovation
    Research Overview

    Dr. Sussman’s research focuses on improving the personal tailoring of medical decisions, particularly for the prevention and treatment of cardiovascular disease and diabetes. He is especially interested in how risk prediction and decision analysis can be used with implementation science, and clinical policy to improve clinical practice and patient-centered care. His work on risk prediction has examined the use of Big Data in clinical care. His work on health policy looks at quality measurement as a tool of implementation science. He has used large datasets, randomized trials, survey research, and qualitative study designs.

    Recent Publications See All Publications
    • Journal Article
      Atherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events Equations.
      Anderson TS, Wilson LM, Sussman JB. JAMA Intern Med, 2024 Aug 1; 184 (8): 963 - 970. DOI:10.1001/jamainternmed.2024.1302
      PMID: 38856978
    • Preprint
      Testing the feasibility and acceptability of ‘Everyday SDM’ in primary care: Protocol for a pilot implementation study (Preprint)
      Dorin SS, Schulenberg FB, Visnic S, Youles B, Holleman R, Sussman JB, Caverly TJ. JMIR Preprints, DOI:10.2196/preprints.64998
    • Journal Article
      Effect of Population-Level Blood Pressure Treatment Strategies on Cardiovascular and Cognitive Outcomes.
      Burke JF, Sussman JB, Yaffe K, Hayward RA, Giordani BJ, Galecki AT, Whitney R, Briceño EM, Gross AL, Elkind MSV, Manly JJ, Gottesman RF, Gaskin DJ, Sidney S, Levine DA. Circ Cardiovasc Qual Outcomes, 2024 Jun; 17 (6): e010288 DOI:10.1161/CIRCOUTCOMES.123.010288
      PMID: 38813695
    • Preprint
      Scoping review of dashboards in health care: why, how, and for whom they have been developed, implemented, and evaluated (Preprint)
      Helminski D, Sussman JB, Pfeiffer PN, Kokaly AN, Ranusch A, Renji AD, Damschroder LJ, Landis-Lewis Z, Kurlander JE. JMIR Preprints, DOI:10.2196/preprints.59828
    • Journal Article
      Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data.
      Yoo SGK, Chung GS, Bahendeka SK, Sibai AM, Damasceno A, Farzadfar F, Rohloff P, Houehanou C, Norov B, Karki KB, Azangou-Khyavy M, Marcus ME, Aryal KK, Brant LCC, Theilmann M, Cífková R, Lunet N, Gurung MS, Mwangi JK, Martins J, Haghshenas R, Sturua L, Vollmer S, Bärnighausen T, Atun R, Sussman JB, Singh K, Moghaddam SS, Guwatudde D, Geldsetzer P, Manne-Goehler J, Huffman MD, Davies JI, Flood D. Glob Heart, 2024 19 (1): 44 DOI:10.5334/gh.1323
      PMID: 38708405
    • Preprint
      Associations Between Stroke Type, Ischemic Stroke Subtypes, and Post-Stroke Cognitive Trajectories.
      Levine DA, Whitney RT, Ye W, Briceño EM, Gross AL, Giordani BJ, Sussman JB, Lazar RM, Howard VJ, Aparicio HJ, Beiser AS, Elkind MSV, Gottesman RF, Koton S, Pendlebury ST, Kollipara AS, Springer MV, Seshadri S, Romero JR, Fitzpatrick AL, Longstreth WT, Hayward RA. 2024 May 1; DOI:10.1101/2024.04.29.24306600
      PMID: 38903102
    • Journal Article
      Development and validation of the Michigan Chronic Disease Simulation Model (MICROSIM).
      Burke JF, Copeland LL, Sussman JB, Hayward RA, Gross AL, Briceño EM, Whitney R, Giordani BJ, Elkind MSV, Manly JJ, Gottesman RF, Gaskin DJ, Sidney S, Yaffe K, Sacco RL, Heckbert SR, Hughes TM, Galecki AT, Levine DA. PLoS One, 2024 19 (5): e0300005 DOI:10.1371/journal.pone.0300005
      PMID: 38753617
    • Journal Article
      Clinical Care for Life's Essential 8 by Medical Specialty in the United States, an Observational Cohort Study.
      Johansen ME, Sterling MR, Sussman JB. Circ Cardiovasc Qual Outcomes, 2024 Apr; 17 (4): e010498 DOI:10.1161/CIRCOUTCOMES.123.010498
      PMID: 38525597
    Featured News & Stories heart drawing
    Health Lab
    New risk equation could mean preventive statins for far fewer Americans
    The tool, based on updated information about atherosclerotic cardiovascular disease, could mean fewer people would be recommended to take statin medications